[Laferon in the treatment of meningoencephalitis].
Administration of laferon to patients stimulates the blood serum interferon formation, with its peak being reached by 24 h. The evaluation done confirmed the therapeutic efficacy of laferon in meningoencephalites. This was manifested by reduction in duration of certain clinical symptoms, timeterms of spinal fluid sanitation, improvement in immunity parameters and increase in the patients' blood serum level of interferon.
Rudenko
A A
AA
Muravskaia
L V
LV
Trinus
E K
EK
Sidorova
Zh P
ZhP
Parkhomets
B A
BA
Diadiun
S T
ST
Nogachevskii
I I
II
Kordium
V A
VA
Volevach
A A
AA
Chegusov
P V
PV
D000258:Adenovirus Infections, Human / Q000276:immunology / Q000628:therapy*; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D004769:Enterovirus Infections / Q000276:immunology / Q000628:therapy*; D005260:Female; D006566:Herpesviridae Infections / Q000276:immunology / Q000628:therapy*; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology; D007251:Influenza, Human / Q000276:immunology / Q000628:therapy*; D007370:Interferon Type I / Q000627:therapeutic use*; D007372:Interferons / Q000097:blood / Q000187:drug effects; D008297:Male; D008590:Meningoencephalitis / Q000276:immunology / Q000628:therapy*; D008875:Middle Aged; D011994:Recombinant Proteins; D012397:Rosette Formation; D013997:Time Factors
D000998:Antiviral Agents; D007370:Interferon Type I; D011994:Recombinant Proteins; D007372:Interferons